| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| Cost of Revenue | $0 | — | — |
| Gross Profit | $0 | — | — |
| R&D Expense | $0 | — | — |
| SG&A Expense | $73K | +14.0% | +12.7% |
| Operating Income | -$73K | -14.0% | -12.7% |
| Interest Expense | $14K | -70.5% | — |
| Net Income | -$44K | +61.2% | +36.8% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12K | +57.8% | -73.4% |
| Current Assets | $15K | +33.5% | -70.6% |
| Total Assets | $15K | +33.5% | -70.6% |
| Current Liabilities | $2.5M | -1.4% | -2.8% |
| Stockholders' Equity | -$2.5M | +1.5% | +1.4% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$78K | -64.4% | — |
| Financing Cash Flow | $75K | +87.5% | — |